Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy | Zendy

Eswari Dodagatta-Marri | Zendy; HsiaoYen Ma | Zendy; Benjia Liang | Zendy; John Li | Zendy; Dominique S. Meyer | Zendy; Szu-Ying Chen | Zendy; Kai-Hui Sun | Zendy; Xin Ren | Zendy; Bahar Zivak | Zendy; Michael D. Rosenblum | Zendy; Mark B. Headley | Zendy; Lauren Pinzas | Zendy; Nilgun Isik Reed | Zendy; Joselyn S. Del Cid | Zendy; Byron Hann | Zendy; Sharon Yang | Zendy; Anand Giddabasappa | Zendy; Kavon Noorbehesht | Zendy; Bing Yang | Zendy; Joseph Dal Porto | Zendy; Tatsuya Tsukui | Zendy; Kyle Niessen | Zendy; Amha Atakilit | Zendy; Rosemary J. Akhurst | Zendy; Dean Sheppard | Zendy

Open Access

Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

Author(s) -

Eswari Dodagatta-Marri,

HsiaoYen Ma,

Benjia Liang,

John Li,

Dominique S. Meyer,

Szu-Ying Chen,

Kai-Hui Sun,

Xin Ren,

Bahar Zivak,

Michael D. Rosenblum,

Mark B. Headley,

Lauren Pinzas,

Nilgun Isik Reed,

Joselyn S. Del Cid,

Byron Hann,

Sharon Yang,

Anand Giddabasappa,

Kavon Noorbehesht,

Bing Yang,

Joseph Dal Porto,

Tatsuya Tsukui,

Kyle Niessen,

Amha Atakilit,

Rosemary J. Akhurst,

Dean Sheppard

Publication year - 2021

Publication title -

cell reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2021.109309

Subject(s) - cytotoxic t cell , cancer research , immunotherapy , granzyme b , biology , cancer immunotherapy , cd8 , il 2 receptor , immunology , t cell , antigen , immune system , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore